GILD

Gilead Sciences, Inc. News Headlines

$93.79
*  
2.50
2.74%
Get GILD Alerts
*Delayed - data as of Dec. 26, 2014  -  Find a broker to begin trading GILD now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    GILD Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Speculators On The Next HCV Acquisition Should Not Overlook Technological Platforms
6/20/2014 10:25:00 AM - Seeking Alpha


Cramer's Lightning Round - I Always Come Back To Palo Alto Networks (6/19/14)
6/20/2014 6:35:00 AM - Seeking Alpha


Sovaldi And Drug Pricing: The United States Of Saps
6/19/2014 3:36:00 AM - Seeking Alpha


Should You Add To Your Holdings In These H&Q Biotechnolgy Funds?
6/18/2014 6:09:00 PM - Seeking Alpha


Hepatitis C May Give A Big Boost To These Drug Stocks - If The FDA Approves
6/17/2014 1:32:00 PM - Seeking Alpha


Maxim's $22 Price Target On Achillion Is Far From Realistic
6/17/2014 3:33:00 AM - Seeking Alpha


Market Consensus For Gilead's Q2 Revenue At $5.3B Is $0.5B Light
6/16/2014 10:05:00 AM - Seeking Alpha


InterMune's A Strong Buy As Esbriet Finally Has The Data Physicians, Patients, And FDA Have Longed For
6/14/2014 5:00:00 AM - Seeking Alpha


What Is Next For The Hepatitis C Space?
6/13/2014 10:17:00 AM - Seeking Alpha


Biotech Stocks Get Turbo Boost From Idenix Deal
6/11/2014 6:45:00 PM - Seeking Alpha


Why Did Merck Pay Such A Huge Premium For Idenix
6/11/2014 6:43:00 PM - Seeking Alpha


Merck - Getting Serious About Hepatitis C After Acquiring Idenix
6/11/2014 8:44:00 AM - Seeking Alpha


Merck's Acquisition Of Idenix Pharmaceuticals Is An Admission Of Inferiority To Sovaldi Regimens
6/10/2014 5:47:00 PM - Seeking Alpha


Cramer's Mad Money - Has Carl Icahn Lost His Mind? (6/9/14)
6/10/2014 5:12:00 AM - Seeking Alpha


Gilead Sciences: Killing The Competition With Sovaldi; But Does This Make Gilead A One-Trick Pony?
6/9/2014 6:08:00 PM - Seeking Alpha


Gilead Down On Merck-Idenix Deal, But Little To Fear
6/9/2014 2:17:00 PM - Seeking Alpha


Long-Term Opportunity In Tech Sector Volatility
6/6/2014 7:48:00 PM - Seeking Alpha


Focus On Catalysts To Cash In On Biotech: Jason Kolbert
6/6/2014 1:30:00 PM - Seeking Alpha


Cramer's Lightning Round - People Will Come Back To Charles Schwab (6/5/14)
6/6/2014 5:02:00 AM - Seeking Alpha


Gilead Valuations Set To Look Better In 12 Months
6/5/2014 12:30:00 PM - Seeking Alpha


Cramer's Mad Money - Father Versus Son (5/27/14)
5/28/2014 6:23:00 AM - Seeking Alpha


Recent Developments In Gilead's Non-Hepatitis C Programs
5/27/2014 10:38:00 AM - Seeking Alpha


4 Best-In-Class Growth And Value Stocks
5/26/2014 3:42:00 AM - Seeking Alpha


Naysayers Are Wrong: Rohit Vanjani On How To Make Money With Generics, Diagnostics
5/23/2014 4:31:00 PM - Seeking Alpha


Gilead: Sovaldi Pricing Ethically And Economically Justified
5/22/2014 3:17:00 PM - Seeking Alpha